Walter Schmidt
25Patents
8h-index
29Co-inventors
75Inventor score
Filing activity: Sep 23, 1992 → Jul 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5547932A | Composition for introducing nucleic acid complexes into higher eucaryotic cells | Emerging Cross-Sectional Technologies | 256 | Expired |
| US6869607B1 | Vaccine formulations | Human Necessities | 54 | Expired |
| US7148191B2 | Antigenic composition | Chemistry; Metallurgy | 38 | Expired |
| US6022735A | Composition for introducing nucleic acid complexes into higher eucaryotic cells | Emerging Cross-Sectional Technologies | 34 | Expired |
| US6274322A | Composition for introducing nucleic acid complexes into higher eucaryotic cells | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6077663A | Composition for introducing nucleic acid complexes into higher eucaryotic cells | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5981273A | Composition comprising an endosomolytic agent for introducing nucleic acid complexes into higher eucaryotic cells | Chemistry; Metallurgy | 23 | Expired |
| US7105162B1 | Pharmaceutical composition for immunomodulation based on peptides and adjuvants | Chemistry; Metallurgy | 13 | Expired |
| US7244438B2 | Uses for polycationic compounds | Human Necessities | 7 | Expired |
| US7528223B2 | Antigens encoded by alternative reading frames from pathogenic viruses | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7935348B2 | Combination therapy for the treatment of Alzheimer's disease | Human Necessities | 4 | Active |
| US7935252B2 | Methods of treating Alzheimer's Disease with an apheresis device | Human Necessities | 3 | Active |
| US8022180B2 | Method for preventing and treating Alzheimer's disease | Physics | 3 | Active |
| US8618046B2 | Treatment of atherosclerosis with cholesterol ester transport protein mimotopes | Human Necessities | 1 | Active |
| US9625459B2 | Method for diagnosing alzheimer's disease (AD) | Physics | 1 | Active |
| US10646565B2 | Treatment of alzheimer'S disease (AD) with an aluminum salt | Human Necessities | 1 | Active |
| US11147873B2 | Treatment of Alzheimer's Disease (AD) with an aluminum salt | Human Necessities | 1 | Active |
| US11065273B2 | Treatment and prevention of alzheimer's disease (AD) | Human Necessities | 1 | Active |
| US8945591B2 | Methods and compositions involving immunostimulatory oligodeoxynucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
| US10478454B2 | Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide | Human Necessities | 0 | Active |
| US11857568B2 | Treatment and prevention of Alzheimer's disease (AD) | Human Necessities | 0 | Active |
| US9029327B2 | Vaccine | Human Necessities | 0 | Active |
| US7858588B2 | Immunostimulatory oligodeoxynucleic molecules | Chemistry; Metallurgy | 0 | Expired |
| US8568742B2 | Methods and compositions involving immunostimulatory oligodeoxynucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
| US9492537B2 | Methods and compositions involving immunostimulatory oligodeoxynucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.